You are here

Gynecologic oncology DOI:10.1016/j.ygyno.2014.06.026

Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.

Publication TypeJournal Article
Year of Publication2014
AuthorsWik, E, Trovik, J, Kusonmano, K, Birkeland, E, Raeder, MB, Pashtan, I, Hoivik, EA, Krakstad, C, Werner, HM, Holst, F, Mjøs, S, Halle, MK, Mannelqvist, M, Mauland, KK, Oyan, AM, Stefansson, IM, Petersen, K, Simon, R, Cherniack, AD, Meyerson, M, Kalland, KH, Akslen, LA, Salvesen, HB
JournalGynecologic oncology
Date Published2014/07/01

Our previously reported 29-gene expression signature identified an aggressive subgroup of endometrial cancer patients with PI3K activation. We here wanted to validate these findings by independent patient series.